Stay updated on Pembrolizumab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.5.3 now appears, replacing Revision: v3.5.2. This indicates a small backend or template update without altering the study data or visible content.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedFooter revision label updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check48 days agoChange DetectedThe history log now lists a new revision version v3.5.0 and the deletion of v3.4.3.SummaryDifference0.0%

- Check55 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check83 days agoChange DetectedThe page history now includes a new revision entry v3.4.2, and the older revision entry v3.4.1 as well as a government-funding notice were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check90 days agoChange DetectedAdded a site-wide notice about potential delays due to a lapse in government funding. Updated the system revision to v3.4.1 and removed the previous revision v3.4.0.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Solid Tumors Clinical Trial page.